Chapter 79: Insulin, Glucagon, and Diabetes Mellitus

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Usually when we talk about a medical diagnosis,

there's this comforting expectation of precision, you know?

Oh yeah, like it's engineering.

Right, exactly.

Like you break your arm, the x -ray shows a jagged white line and the doctor just points to it and says, there it is.

It's binary.

It's either broken or not broken.

It's visible and that visibility, I think, makes us feel like we understand exactly what's going wrong in the body.

But the moment you step into the world of medical physiology and specifically how our bodies manage and distribute energy,

that x -ray machine is, well, it's entirely useless.

Absolutely useless, so to you, the listener, welcome to today's deep dive.

Our mission today is actually pretty specific.

We are delivering a master class in medical physiology, perfectly designed for, say, a college student who is tackling this dense material for the very first time.

And we're going straight to the source, following the exact step -by -step logic of chapter 79 from the Gaiden and Hall textbook of medical physiology, 15th edition.

Right, and we are going in the exact order of the text because this chapter reveals an incredibly brilliant, literally life -or -death logical chain.

We've all heard the buzzwords, right?

Blood sugar, insulin.

Oh, sure.

Everyone knows those words.

But we're going to see how it goes from microscopic cellular anatomy to full -body regulation and then ultimately what happens when it all breaks down to diabetes mellitus.

And this story starts with a physical origin point.

Think about your pancreas.

Yeah, sitting right there quietly behind your stomach.

If you were to look at the anatomy of the pancreas and the text actually opens with a great diagram, figures 79 .1 to show this, you'd see it's essentially two entirely different organs matched together into one.

Two organs, like distinct tissues.

Exactly.

So the vast majority of the tissue is made up of what are called axini, and their job is pretty straightforward.

They just manufacture digestive juices and secrete them right into your blood.

But floating throughout that massive sea of digestive tissue are about one to two million tiny distinct clusters of cells.

Wow.

One to two million.

I always picture them as like these highly secure microscopic command centers floating in this ocean of digestive fluid.

They have a completely different mission.

That is a really great way to visualize them.

The text calls these clusters the islets of Langerhans, and each one is just a fraction of a millimeter across.

But they are woven incredibly tightly around tiny capillaries.

So they have direct access to the blood.

Right.

The moment they produce a hormone, they can dump it directly into the bloodstream.

It's immediate.

And inside these little island command centers, you essentially have three main types of personnel.

First, you have the beta cells, which make up the majority.

About 60%.

Right, 60%.

And they sit right in the middle of the islet, producing insulin and another hormone called amylin.

Then surrounding them are the alpha cells, which are about 25 % of the islet, and they secrete glucagon.

And finally, you have the delta cells making up the last 10%, producing somatostatin.

But the textbook makes a really interesting point here.

It isn't just about what they produce.

It's how they interact.

Right.

Yes, the paracrine communication.

Essentially, they are just constantly whispering to each other across the islet.

So they are just blindly pumping out hormones into the void.

They are like auditing each other's work to keep our fuel levels completely stable.

Precisely.

The insulin from the beta cells actively inhibits the alpha cells from releasing glucagon.

The amylin inhibits the insulin, and the somatostatin just, well, it inhibits everything.

Wow.

It's this hyper local, tightly controlled feedback loop that happens before these hormones ever even reach the rest of the body.

Okay.

So since those beta cells make up the bulk of this operation, let's unpack their primary job.

How does a beta cell actually manufacture insulin?

Because, I mean, it's not just mixing two chemicals together in a vat.

No, not at all.

It's a highly coordinated assembly line.

And figure 79 .2 in the chapter maps this out beautifully.

It starts deep inside the beta cell on the endoclasmic reticulum.

Okay.

There, ribosomes translate genetic instructions into this massive clunky protein chain called pre -pro insulin.

Wait, so the body makes a giant unusable protein just to like immediately start chopping it up.

It sounds super inefficient, I know, but that large structure is chemically necessary for the protein to fold itself correctly.

Once it is folded, enzymes chop off a section, leaving a three chain structure called pro insulin.

That's chains A, B, and C.

Got it.

Then it moves into the cell's shipping department, the Golgi apparatus, where it gets snipped one last time.

And this final snip is the really crucial one, right?

Yes, exactly.

The A and B chains stay hooked together by disulfide bonds.

That is your final active insulin molecule.

But that middle section, the C chain, is fully detached.

It's now called C peptide.

Okay.

So they're separated.

Right.

But both the active insulin and the inactive C peptide are packaged into the exact same little storage bubbles, the granules, just waiting to be released.

Now, here's a fascinating takeaway from the text.

The C peptide doesn't lower your blood sugar at all.

It has virtually no insulin activity.

But clinically, for doctors, it is an absolute goldmine for diagnostics.

It really is.

And the reason is that the beta cell release is exactly one molecule of C peptide for every one molecule of insulin.

They are secreted in equimolar amounts.

So let's say you have a diabetic patient who is injecting synthetic insulin every day to manage their blood sugar.

You can't just measure their blood insulin levels to see if their pancreas is still working, right?

Right.

Because you'd mostly be measuring the drug they just injected.

Right.

The test wouldn't know the difference.

But the synthetic stuff, the drug doesn't contain C peptide.

So by measuring the C peptide in their blood, doctors have this amazing built -in tracking device.

It tells them exactly how much natural insulin the patient's own body is still capable of manufacturing.

That's brilliant.

Now once the real insulin hits the bloodstream, the book notes it has a surprisingly short lifespan.

It's cleared by an enzyme called insulinase, mostly in the liver, in just, what, 10 to 15 minutes?

Yeah, 10 to 15 minutes.

And that rapid clearance is entirely by design.

Think about it.

Insulin is an aggressive command to the body to store energy.

If the body suddenly needs to turn off that store energy signal because, say, blood sugar is dropping too

it cannot wait hours for the hormone to degrade.

It has to fade incredibly fast.

So in that short 15 minute window, this insulin molecule is floating through the blood and finds a target cell, maybe a muscle cell or a fat cell.

How does it actually force that cell to absorb glucose?

Well, the old high school biology analogy is always the key fitting into a lock.

Right.

But looking at the actual physiology in figure 79 .3, that feels way too simple.

Oh, it is.

The key in a lock implies a direct mechanical opening.

The reality is so much more complex.

The insulin receptor is this massive enzyme -linked structure.

It has two alpha subunits sitting on the outside of the cell membrane and two beta subunits extending deep into the inside of the cell.

So a much better analogy would be that insulin is like someone walking up to the outside wall of a massive factory and smashing a master override button.

The button itself doesn't literally open the doors.

It triggers a radio signal to the internal machinery.

I love that metaphor.

That's exactly it.

When insulin binds to the alpha subunits on the outside, the beta subunits inside the cell actually activate themselves.

It's a process called autophosphorylation.

Autophosphorylation.

Right.

And this wakes up a local enzyme inside the cell called tyrosine kinase.

Pyrosine kinase essentially gets on the radio and starts shouting orders to a group of foremen called insulin receptor substrates, or IRS.

And those internal foremen, the IRS, then radio the forklifts.

In this cellular factory, the forklifts are tiny transport vesicles carrying the actual glucose doors,

specifically proteins called GLUT4.

Yes.

And those GLUT4 transporters are normally just parked deep inside the cell doing absolutely nothing.

But once that cascade of signals hits them, they physically drive up to the factory wall, fuse with the cell membrane, and suddenly the doors are wide open.

And the glucose just floods in.

Exactly.

Glucose from the blood floods into the cell.

And the moment the insulin signal stops, those doors literally separate from the membrane and retreat back inside the cell, locking it down again.

Wow.

Okay.

So the doors are open.

The energy is rushing in.

This brings us to insulin's true identity in chapter 79.

It isn't just a, quote, sugar -lowering hormone.

It is the ultimate hormone energy abundance.

The ultimate saver.

Right.

It acts like an incredibly strict, unforgiving financial advisor.

When times are good, like you just ate a huge meal, it demands you save everything and strictly forbids any withdrawals from your accounts.

Let's trace how that financial advisor handles your different biological assets.

Take carbohydrates first.

Figure 79 .4 shows this amazing graph.

When you are resting, your muscles actually prefer to burn fat.

Their membranes are almost completely impermeable to glucose.

But post meal.

Post meal, insulin slams that master override button.

The graph shows that the rate of glucose rushing into the muscle cell spikes at least 15 fold.

15 fold.

And liver takes this hoarding behavior to a whole other level, right?

Oh, the liver is the ultimate storage vault.

Insulin forces liver cells to trap glucose by activating an enzyme called glucokinase.

Glucokinase basically chemically tags the glucose so it physically can't leak back out into the blood.

So it's trapped.

Yep.

Then insulin shuts down the enzymes that break apart old storage and ramps up an enzyme called glycogen synthase to pack that new glucose into dense chains called glycogen.

The liver just packs it in until it's about five to six percent solid glycogen by weight.

But the text highlights one massive crucial exception to this rule.

The human brain.

The brain doesn't have to listen to the financial advisor at all.

The brain is completely exempt.

Brain cells are permeable to glucose without insulin.

They require a constant uninterrupted supply of energy regardless of whether you just ate or if you're fasting.

Okay, so insulin hoards the carbs.

But what about fats?

If this hormone is truly a strict financial advisor, it must have a plan for our fat cells too.

It definitely does.

Insulin is technically referred to as a fat sparer.

If that liver vault we just talked about hits its absolute maximum capacity for glycogen.

Insulin doesn't just throw the extra glucose away.

Right.

It forces the liver to convert all remaining glucose into fatty acids, packages them into VLDLs and ships them to your fat cells for long -term storage.

And here's where that no -withdrawals rule comes in, right?

Precisely.

At the same time it's storing fat, insulin actively inhibits an enzyme called hormone -sensitive lipase.

That lipase is the only thing that breaks down stored fat into

So as long as insulin is present in your blood, you can make deposits into your fat cells, but the withdrawal window is permanently locked.

Permanently.

And you know, this demanding nature even extends to proteins.

Insulin forces your cellular machinery to synthesize new proteins and aggressively halts the breakdown of existing ones.

Yeah, there's this incredible experiment detailed in figure 79 .6 that demonstrates this synergy perfectly.

Imagine a laboratory rat that had its pancreas and pituitary gland removed.

So no insulin and no growth hormone.

Exactly.

It has as well no insulin and absolutely no growth hormone.

As you'd expect, the rat stops growing entirely.

If you inject it with just growth hormone, nothing happens.

Right.

If you inject it with just insulin, still nothing.

But the moment you provide both simultaneously, the graph shows the rat growing rapidly.

It's wild.

It proves that you cannot build new tissue, and how not grow without the aggressive energy saving and protein building directives of insulin.

Growth hormone alone just doesn't have the metabolic authority to get the job done.

So if insulin wields all this metabolic power,

how does that tiny beta cell actually know when to deploy it?

How does it sense that I just ate a massive bowl of pasta?

Let's slow down here because the mechanism, the beta cell battery is incredibly elegant.

It really is.

It all comes down to a specialized sensor.

If you look at figure 79 .7, it walks through this step by step.

The beta cell has a type of glucose door on its surface called GLUT2.

Unlike the doors on muscle cells, GLUT2 is always open.

It doesn't need an insulin signal.

So whatever the sugar concentration is in my blood, that exact same concentration is mirroring itself inside the beta cell.

Exactly.

When you eat that pasta, glucose floods into the beta cell.

Immediately that enzyme, glucokinase, tags it so it can't escape.

That's the rate limiting step.

The cell then metabolizes that trapped glucose, burning it to create ATP, which is cellular energy.

Let me make sure I'm tracking this sequence.

The more sugar in the blood, the more enters the cell.

The more that enters, the more gets metabolized, which means the cell produces a huge surge of ATP.

It's literally acting like a little glucose powered battery.

Yes.

And that surge of ATP flips an electrical switch.

On the surface of the beta cell are these ATP sensitive potassium channels.

Normally they leak potassium outward, keeping the cell's internal electrical charge negative.

But ATP binds to these channels and forces them shut.

So the potassium gets trapped inside.

Right.

And because potassium is positively charged, the inside of the cell rapidly becomes positive.

It depolarizes.

The sudden voltage flip pops open a different set of doors, voltage gated calcium channels.

Calcium rushes into the cell.

It's that flood of calcium that acts as the final trigger, right?

It physically pushes those storage bubbles full of insulin to the cell wall so they can be dumped into the blood.

That's the chain reaction.

Glucose makes ATP, ATP traps potassium, the voltage flips, calcium rushes in, insulin dumps out.

Wow.

And it's fascinating that this dump happens in two distinct stages.

The textbook has a graph, figure 79 .8, showing a person's levels after a sudden spike in blood sugar.

And it's not just one smooth curve.

No, not at all.

You see this massive rapid spike within three to five minutes.

That's the beta cell emptying all its preformed storage vesicles at once.

But that first wave fades pretty quickly.

And then?

Then, starting around 15 minutes later, you see a second slower wave that rises even higher and lasts for hours.

That is the beta cell actively synthesizing brand new insulin from scratch to handle the food.

It's just so smart.

And it's not just reacting to glucose either.

The text mentions that certain amino acids from digesting protein strongly potentiate or amplify this insulin release.

Which, I mean, makes sense.

If you eat a piece of chicken, you need insulin to help push those amino acids into your cells to build muscle.

Definitely.

There's also this amazing anticipatory mechanism.

When food hits your stomach and intestines, your gut releases gastrointestinal hormones called incretins, specifically ones called GLP -1 and GIP.

Before a single molecule of glucose actually enters your blood, these incretins travel to the pancreas and tell it, hey, food is coming.

Ramp up the battery now.

That gut brain pancreas communication is just so fast.

And just to tie this to real world medicine, the book points out a class of diabetes drugs called sulfonylureous.

Oh, yeah.

They work by artificially latching onto those potassium channels on the beta cell and just forcing them shut.

They completely bypass the glucose and just force the battery to depolarize and squeeze out insulin.

It's literally a pharmacological hijack of the natural system.

It just forces the pancreas to work harder.

OK, so that brilliantly explains how we handle the abundance of a massive meal.

But what happens six hours later?

You're asleep.

The meal is fully absorbed.

The battery winds down and your blood is steadily dropping toward a dangerously low level.

We need a countermeasure.

Enter glucagon, secreted by the alpha cells.

If insulin is the financial advisor demanding you save, glucagon is the emergency responder forcing you to liquidate your assets immediately.

Its entire job is to raise blood sugar.

The textbook details how glucagon forces the liver to break down its stored glycogen, a process called glycogenolysis.

And the way it does this isn't a direct one -to -one action.

It's more like a cellular, multi -level marketing scheme.

That is the perfect way to describe an amplification cascade.

Glucagon doesn't just chop up glycogen itself.

One molecule of glucagon binds to a G protein -coupled receptor on the liver cell.

That single receptor activates adenylcicilius, which manufactures dozens of secondary messenger molecules called CAMP.

Those wake up hundreds of protein kinases, which activate thousands of phosphorylase B kinases, which activate even more phosphorylase A.

So one boss recruits ten managers who recruit a hundred foremen who recruit a thousand workers.

Exactly.

This staggering amplification is why just a microscopic microgram of glucagon can multiply its signal a million -fold, violently dumping massive amounts of glucose into your blood in minutes.

And if the liver vault runs completely empty, glucagon then shifts gears and forces the liver into gluconeogenesis.

It literally synthesizes brand new glucose out of spare amino acids.

Now I noticed a really fascinating biological paradox here in the text.

High blood sugar shuts down glucagon.

But high blood amino acids, like if you ate a meal of pure protein and zero carbs,

actually stimulate both insulin and glucagon at the same time.

Why would the body fire both the brake and the gas?

Think of the danger of a pure protein meal.

The amino acids trigger your beta cells to release insulin so you can store that protein.

But remember, insulin isn't picky.

It also sweeps whatever baseline glucose you have in your blood into your cells.

If you didn't have a counter measure, a pure protein meal would crash your blood sugar and you'd pass out.

So the amino acids also trigger the alpha cells to release glucagon.

The glucagon forces the liver to output just enough glucose to perfectly counterbalance the insulin's side effect.

It's an incredibly elegant biological safety net.

And just to complete the islet team, we have somatostatin from the delta cells.

Tripped by eating, it acts as a global brake pedal.

Slowing things down.

Yeah.

It depresses both insulin and glucagon and physically slows down the motility of your stomach and intestines.

Its whole purpose is to stretch out the assimilation time so your bloodstream isn't overwhelmed by a sudden avalanche of nutrients.

So we have the complete picture now.

Insulin pushes energy into storage, glucagon violently pulls it back out, and somatostatin smooths the ride.

How tightly does this integrated system actually govern our blood?

Very tightly.

In a healthy person, fasting blood glucose is rigidly maintained between 80 and 90 milligrams per deciliter.

After a heavy meal, it might briefly spike to 120 or 140.

But this integrated feedback loop wrestles it back to baseline usually within two hours.

And the liver acts as the massive shock absorber here, storing up the excess and slowly releasing it, decreasing the fluctuations by about two thirds.

But I have to ask a naive question here.

Earlier we said the brain is absolutely desperate for glucose.

If the brain is so incredibly greedy for it, why does the body fight so hard to keep blood sugar down at 90?

Why not just let it run high all the time so the brain is never hungry?

Because chronically high glucose is incredibly toxic.

Physically, high glucose exerts immense osmotic pressure.

It literally acts like a sponge, sucking water out of your surrounding cells and causing severe cellular dehydration.

And all that pulled water has to go somewhere.

It heads to the kidneys.

When blood sugar gets too high, it overwhelms the kidney's ability to reabsorb it.

The sugar spells over into your urine, dragging all that pulled water with it, causing osmotic diuresis, which is massive fluid and electrolyte loss.

Yikes.

Furthermore, chronic high sugar binds to proteins and fundamentally shreds the structural integrity of your blood vessels over time, leading to heart attacks, strokes, and blindness.

The regulation isn't just about weight gain.

It is literally an immediate matter of life and death, which brings us to the clinical combination of everything we've discussed.

When this anatomy fails, the function breaks down, the regulation collapses, and we arrive at diabetes mellitus.

Let's break down the two main types.

Type 1 diabetes accounts for about 5 to 10 % of cases.

This is a structural failure.

Usually due to a viral trigger or an autoimmune disorder, the body's own immune system attacks the pancreas and completely destroys the beta cells.

So the command centers are just wiped out.

No beta cells mean zero insulin.

Right.

The onset is early and abrupt, usually in childhood.

Without insulin, blood glucose skyrockets.

As we just said, it spills into the urine, pulling massive amounts of water, causing severe polyuria, which is constant urination, and deep dehydration.

But the secondary metabolic shift is what's truly terrifying.

Without insulin acting as the strict financial advisor, that hormone -sensitive lipase in the fat cells loses its inhibitor.

The withdrawal window is kicked wide open.

The body goes into pure starvation mode.

It starts frantically burning fat exclusively.

The liver gets flooded with so many fatty acids that it can't process them normally, so it converts them into highly acidic keto acids, like acetoacetic acid.

And figure 79 .1 in the text graphs this out.

It shows the pH of the patient's blood plummeting from a healthy 7 .4 down to 6 .9 or lower, plunging them into a diabetic coma.

It's metabolic acidosis.

And some of these acids convert into acetone, which evaporates from the cells, almost like fruity nail polish remover.

It is such a tragic biological irony.

An untreated type 1 diabetic can eat massive amounts of food experiencing extreme hunger.

Yet because the master override button is never pressed, the cells remain locked shut.

They literally starve to death and waste away while their blood is thick with unusable fuel.

The only treatment is absolute insulin replacement.

Let's contrast that with type 2 diabetes, which makes up 90 -95 % of cases.

This doesn't start with a broken command center.

It starts with a broken receptor.

Correct.

It begins with insulin resistance.

The target cells in the muscle, liver, and fat simply stop responding to the signal.

Going back to our factory analogy,

the override button is being pressed on the outside wall, but the internal radios are staticky in the form and aren't listening to the orders, so the doors stay shut.

Exactly.

This resistance is heavily linked to obesity, excess visceral fat, and a cluster of conditions known as metabolic syndrome.

Initially, the pancreas compensates.

The beta cells realize the signal isn't getting through, so they work over time.

Pumping out more insulin.

Right.

They pump out massive amounts of insulin hyperinsulinemia, screaming into the void to try and force those doors open.

But eventually they just burn out.

The beta cells become exhausted and dysfunctional.

They can no longer produce enough insulin to overpower the resistance, and that's when blood sugar permanently rises and clinical symptoms appear.

The chapter outlines how diagnosing this relies on two main tools.

First is a functional test.

The glucose tolerance curve, shown in figure 79 .12.

You give a fasting patient a massive sugary drink.

In a healthy person, their blood sugar spikes, but is wrestled back to normal within two hours.

But in a diabetic person, the curve shows the sugar spiking massively and just staying there for four to six hours because the insulin isn't working.

And the second tool is arguably more vital.

HbA1c, or glycated hemoglobin.

We know that red blood cells live in circulation for roughly 120 days.

When blood sugar is chronically high,

that excess glucose physically sticks to the hemoglobin inside those red blood cells.

So by measuring the percentage of hemoglobin that has sugar permanently stuck to it, doctors aren't just seeing a snapshot of today.

They are getting a highly accurate 120 -day historical average of the patient's blood sugar control.

That's amazing.

As for treating type 2, the primary interventions are lifestyle weight loss and exercise to resensitize the receptors,

and metabolic periatric surgery.

But the pharmacology is fascinating.

You have drugs like metformin, and then there are SGLT2 inhibitors.

When I read how these work, I was blown away.

They basically target the kidneys and block them from reabsorbing glucose so the patient literally just pees the excess sugar away.

It's a mechanical drain for the blood sugar.

It's an incredibly effective workaround.

We also increasingly use those creatin hormones we discussed earlier, the GLP -1 and GIP agonists.

These drugs artificially boost the food is coming signal, dramatically increasing insulin secretion while also causing massive weight loss.

And just to briefly touch on the complete opposite end of the spectrum before we wrap up, the textbook mentions a condition called an insulinoma.

This is a rare hyperactive tumor of the islet cells.

Instead of producing no insulin, the tumor pumps out massive unregulated amounts of it.

Which triggers insulin shock or hypoglycemia.

The blood sugar drops so drastically low that the brain is entirely starved of its only fuel source.

The nervous system becomes highly excitable, leading to hallucinations, sweating, and eventually coma.

And the immediate reversal for that is pumping intravenous glucose straight into the blood.

Right, to feed the brain instantly.

We started today by peering at a tiny fraction of a millimeter island of cells.

And by following the logical chain, we've unspooled the blueprint for one of the most widespread metabolic diseases on the planet.

And if there is one final provocative thought to leave you with,

it's the profound potential of that gut brain pancreas access.

Think about how those in creatin hormones from the intestine can anticipate a meal and manipulate insulin before blood sugar even shifts.

This anticipatory signaling is currently revolutionizing how we treat obesity and metabolic syndrome.

It forces us to ask, what other metabolic secrets, what other chemical whispers is the gut sending through our bodies before food even enters the bloodstream?

It makes you look at every meal you eat in an entirely different light.

The machinery operating behind the scenes is nothing short of miraculous.

Thank you so much for joining us on this Masterclass through Metabolic Physiology.

From all of us on the last -minute lecture team here at the Deem Dive, we wish you the best on your physiology journey.

Keep questioning, keep learning, and we'll see you next time.

β“˜ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
Pancreatic regulation of blood glucose involves a coordinated interplay between insulin, glucagon, and somatostatin secreted from distinct cell populations within the islets of Langerhans. Insulin emerges as the primary anabolic hormone of energy abundance, orchestrating the rapid uptake and storage of glucose, amino acids, and fatty acids across virtually all tissues while simultaneously suppressing catabolic processes. At the cellular level, glucose sensing in beta cells proceeds through glucokinase-catalyzed phosphorylation and subsequent ATP generation, which triggers membrane depolarization and calcium-dependent exocytosis in a biphasic response involving both preformed and newly synthesized hormone pools. Conversely, glucagon functions as the counter-regulatory hormone during energy depletion, mobilizing hepatic glycogen stores and stimulating gluconeogenesis through potent cAMP signaling when blood glucose falls. Somatostatin provides local paracrine feedback to restrain both insulin and glucagon secretion while simultaneously delaying nutrient absorption. The maintenance of fasting glucose within a narrow physiological range reflects the integration of these hormonal mechanisms with hepatic buffering capacity and sympathetic nervous system override during acute stress or hypoglycemia. Diabetes mellitus represents a fundamental disruption of this regulatory system, manifesting as either absolute insulin deficiency through autoimmune beta cell destruction in type 1 diabetes or progressive insulin resistance coupled with beta cell dysfunction in type 2 diabetes. Type 1 presents acutely with severe hyperglycemia, osmotic diuresis, and metabolic acidosis from unopposed ketone body production, requiring insulin replacement therapy. Type 2, accounting for the majority of cases and strongly linked to obesity and metabolic syndrome, initially compensates through beta cell hypersecrection before eventual exhaustion of pancreatic reserve; contemporary management includes insulin sensitizers, incretin-based therapies targeting GLP-1 and GIP pathways, and SGLT2 inhibitors that promote urinary glucose excretion. Diagnosis relies on fasting glucose thresholds, glucose tolerance testing, or glycated hemoglobin measurement reflecting three-month glycemic control. Conversely, insulinomas and other causes of hyperinsulinism create severe hypoglycemia and acute neuroglycopenia requiring immediate parenteral glucose or glucagon administration.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML β™₯